Ming Liu

机构：Memorial University of Newfoundland, Shandong University of Traditional Chinese Medicine, Harbin Medical University, Nanyang Technological University, Peking University, Sichuan University, Wenzhou Medical University, Tianjin Medical University General Hospital, Yuhuangding Hospital, West China Hospital of Sichuan University, First Affiliated Hospital of Guangzhou Medical University, Songshan Lake Materials Laboratory, Hunan Nonferrous Metal Research Institute, Fourth Affiliated Hospital of Harbin Medical University, First Affiliated Hospital of Gannan Medical University, First Affiliated Hospital of Bengbu Medical College, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Impact, Macao Polytechnic University, Lanzhou University, Cardiff University, Guangzhou Medical University, McMaster University · ORCID：0000-0003-2508-4979

发表论文 133 篇 · 总被引 2615 次 · h-index 26

代表论文

Antiviral Medications for Treatment of Nonsevere Influenza (2025 · JAMA Internal Medicine · 被引 39)
DCATNet: polyp segmentation with deformable convolution and contextual-aware attention network (2025 · BMC Medical Imaging · 被引 8)
Targeting the ARL4C/RAP1/PI3K-Akt-mTOR signaling loop promotes ARL4C ubiquitination and reverses oxaliplatin resistance in colorectal cancer (2025 · Theranostics · 被引 5)
Shorter versus longer-duration antibiotic treatments for immunocompetent patients with bloodstream infections: a systematic review and meta-analysis (2025 · EClinicalMedicine · 被引 5)
A multiregional, randomized, controlled, open-label, phase 3 study of the anti-claudin18.2 (CLDN18.2) antibody-drug conjugate (ADC) arcotatug tavatecan (IBI343) in gastric or gastroesophageal junction adenocarcinoma (G/GEJA): Trial in progress. (2025 · Journal of Clinical Oncology · 被引 5)
Efficacy and Safety of Aprocitentan in the Treatment of Hypertension: A Meta-Analysis of Evidence from Randomized Controlled Trials (2025 · Reviews in Cardiovascular Medicine · 被引 5)